BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wen X, Zhou Y, Zeng J, Liu X. Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents. CTMC 2020;20:1441-60. [DOI: 10.2174/1568026620666200128143230] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Acar Çevik U, Celik I, Işık A, Ahmad I, Patel H, Özkay Y, Kaplancıklı ZA. Design, synthesis, molecular modeling, DFT, ADME and biological evaluation studies of some new 1,3,4-oxadiazole linked benzimidazoles as anticancer agents and aromatase inhibitors. J Biomol Struct Dyn 2023;41:1944-58. [PMID: 35037830 DOI: 10.1080/07391102.2022.2025906] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
2 Jin B, Song Y, Ma Y, Zhou Y, Tang G, Wang Y. Syntheses, crystal structure, luminescent properties and Hirshfeld surface of a set of triazole-based salts. Journal of Molecular Structure 2023. [DOI: 10.1016/j.molstruc.2023.134980] [Reference Citation Analysis]
3 Kariuki BM, Abdel-Wahab BF, Mohamed HA, Bekheit MS, El-Hiti GA. Synthesis and Characterization of Novel 2-(1,2,3-Triazol-4-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazoles and 2-(4,5-Dihydro-1H-pyrazol-1-yl)-4-(1H-1,2,3-triazol-4-yl)thiazoles. Molecules 2022;27. [PMID: 36558037 DOI: 10.3390/molecules27248904] [Reference Citation Analysis]
4 Al-wahaibi LH, Karthikeyan S, Blacque O, El-masry AA, Hassan HM, Percino MJ, El-emam AA, Thamotharan S. Structural and Energetic Properties of Weak Noncovalent Interactions in Two Closely Related 3,6-Disubstituted-[1,2,4]triazolo[3,4- b ][1,3,4]thiadiazole Derivatives: In Vitro Cyclooxygenase Activity, Crystallography, and Computational Investigations. ACS Omega. [DOI: 10.1021/acsomega.2c04252] [Reference Citation Analysis]
5 Kumar R, Kamal R, Kumar V, Chetti P. Single Crystal XRD, Spectroscopic, DFT Studies and Synthesis of [1,2,4]triazolo[4,3-a]pyrimidines. Chemical Data Collections 2022. [DOI: 10.1016/j.cdc.2022.100949] [Reference Citation Analysis]
6 Šermukšnytė A, Kantminienė K, Jonuškienė I, Tumosienė I, Petrikaitė V. The Effect of 1,2,4-Triazole-3-thiol Derivatives Bearing Hydrazone Moiety on Cancer Cell Migration and Growth of Melanoma, Breast, and Pancreatic Cancer Spheroids. Pharmaceuticals (Basel) 2022;15:1026. [PMID: 36015174 DOI: 10.3390/ph15081026] [Reference Citation Analysis]
7 Dasari G, Bandari S, Kumar Nukala S, Swamy Thirukovela N, Sirassu N, Badithapuram V, Manchal R. In vitro Anticancer and Insilico Studies of Quinoxaline‐sulfonyl‐1,2,4‐triazole Hybrids. ChemistrySelect 2022;7. [DOI: 10.1002/slct.202200681] [Reference Citation Analysis]
8 Song M, Zhao W, Zhu Y, Liu W, Deng X, Huang Y. Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives. Front Chem 2022;10:925281. [DOI: 10.3389/fchem.2022.925281] [Reference Citation Analysis]
9 Sharma A, Agrahari AK, Rajkhowa S, Tiwari VK. Emerging impact of triazoles as anti-tubercular agent. Eur J Med Chem 2022;238:114454. [PMID: 35597009 DOI: 10.1016/j.ejmech.2022.114454] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Swaminathan S, Haribabu J, Balakrishnan N, Vasanthakumar P, Karvembu R. Piano stool Ru(II)-arene complexes having three monodentate legs: A comprehensive review on their development as anticancer therapeutics over the past decade. Coordination Chemistry Reviews 2022;459:214403. [DOI: 10.1016/j.ccr.2021.214403] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
11 Feng LS, Su WQ, Cheng JB, Xiao T, Li HZ, Chen DA, Zhang ZL. Benzimidazole hybrids as anticancer drugs: An updated review on anticancer properties, structure-activity relationship, and mechanisms of action (2019-2021). Arch Pharm (Weinheim) 2022;:e2200051. [PMID: 35385159 DOI: 10.1002/ardp.202200051] [Reference Citation Analysis]
12 Cao Y, Lu H. Advances in the application of 1,2,4-triazole-containing hybrids as anti-tuberculosis agents. Future Med Chem 2021;13:2107-24. [PMID: 34698509 DOI: 10.4155/fmc-2020-0295] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
13 Rezaei I, Mamaghani M. Green synthesis of bis pyrazole-triazole and azo-linked triazole hybrids using an efficient and novel cobalt nanocatalyst. Reac Kinet Mech Cat 2021;134:385-400. [DOI: 10.1007/s11144-021-02076-8] [Reference Citation Analysis]
14 Xi Y, Chen X, Wu Y, Xue Y, Sun W, Chen X, Liu X, Wang Y, Tang G. The hydroxylic position mediated the luminescent properties based on 4-amino-4H-1,2,4-triazole: Syntheses, crystal structures and Hirshfeld analyses. Journal of Solid State Chemistry 2021;301:122300. [DOI: 10.1016/j.jssc.2021.122300] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hou Y, Shang C, Meng T, Lou W. Anticancer potential of cardiac glycosides and steroid-azole hybrids. Steroids 2021;171:108852. [PMID: 33887267 DOI: 10.1016/j.steroids.2021.108852] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
16 Satpute DP, Vaidya GN, Lokhande SK, Shinde SD, Bhujbal SM, Chatterjee DR, Rana P, Venkatesh A, Nagpure M, Kumar D. Organic reactions in aqueous media catalyzed by nickel. Green Chem 2021;23:6273-300. [DOI: 10.1039/d1gc01983j] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
17 Balewski Ł, Sączewski F, Bednarski PJ, Wolff L, Nadworska A, Gdaniec M, Kornicka A. Synthesis, Structure and Cytotoxicity Testing of Novel 7-(4,5-dihydro-1H-imidazol-2-yl)-2-aryl-6,7-dihydro-2H-imidazo[2,1-c][1,2,4]triazol-3(5H)-Imine Derivatives. Molecules 2020;25:E5924. [PMID: 33327611 DOI: 10.3390/molecules25245924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ge X, Xu Z. 1,2,4-Triazole hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus. Arch Pharm (Weinheim) 2021;354:e2000223. [PMID: 32985011 DOI: 10.1002/ardp.202000223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]